For a study, researchers sought to compare the illness, treatment, comorbidities, and presenting symptoms of a black pediatric Eosinophilic Esophagitis (EoE) group to a non-black pediatric EoE group.
A retrospective document study of pediatric patients at one metropolitan pediatric hospital system who received an EoE diagnosis between 2010 and 2018 found that 143 were black, compared to 142 non-black children, and that the distribution of age and sex was similar in both groups.
Most people in both categories were men, and the median ages at diagnosis for the black and non-black groups were 5.1 and 6.7 years, respectively. Food allergies, atopic dermatitis, asthma, and allergic rhinitis were among the comorbidities more frequently observed in the black group. While non-black patients were more likely to appear with abdominal discomfort, black patients were more likely to present with failure to thrive (FTT)/poor growth. In terms of attaining remission by utilizing the available medications. The black group’s rates of nonadherence to medical treatments were greater.
The research, which contrasted the pediatric EoE populations of black and non-black children, was the biggest to date. The black population presented with considerably higher atopic comorbidities, FTT, and nonadherence problems. The improved awareness, diagnosis, and management of EoE in the community will hopefully result from the new information detailing EoE in a minority population.